ETH Zurich researchers develop light-activated molecular switch to degrade glucocorticoid receptors in tumour cells; Localised therapy with fewer side effects
ETH Zurich researchers develop light-activated molecular switch to degrade glucocorticoid receptors in tumour cells; Localised therapy with fewer side effects Light switch makes cancer vulnerable to attack | ETH Zurich Light switch makes cancer vulnerable to attack Researchers from ETH Zurich have developed a molecular switch that is controlled by light. It wakes lung cancer cells up from a protective dormant state so that they are more accessible for treatment. ...